Placebo News and Research

RSS

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

2 Sep 2020

NAMS publishes the 2020 Genitourinary Syndrome Of Menopause Position Statement

The North American Menopause Society announces publication of its 2020 Genitourinary Syndrome of Menopause Position Statement.

1 Sep 2020

Dr. Fauci says COVID vaccine trials could end early if results are overwhelming

A COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results, said Dr. Anthony Fauci, the nation's top infectious disease official, in an interview Tuesday with KHN.

1 Sep 2020

BCG vaccine offers protection for elderly people against respiratory infections

The BCG vaccine has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections - possibly also against COVID-19. New studies are investigating that.

1 Sep 2020

$Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction$

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with preserved ejection fraction

1 Sep 2020

New dietary intervention improves pain and other symptoms in veterans with Gulf War Illness

A new study from American University shows the results from a dietary intervention in U.S. veterans suffering from Gulf War Illness, a neurological disorder in veterans who served in the Persian Gulf War from 1990 to 1991.

31 Aug 2020

SGLT2 inhibitors can slow CKD progression

850 million people worldwide are affected by chronic kidney disease (CKD) - a worrying figure, and one that continues to rise.

31 Aug 2020

Gout medication reduces major cardiovascular events in heart patients

Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Antihypertensive drugs are not linked to cancer, shows study

There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.

31 Aug 2020

$Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction$

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction.

31 Aug 2020

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

Mavacamten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy, according to results of the EXPLORER-HCM trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalization and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes.

31 Aug 2020

Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes

Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

A coffee and quick catnap can improve alertness during nightshift

A simple coffee and a quick catnap could be the cure for staying alert on the nightshift as new research from the University of South Australia shows that this unlikely combination can improve attention and reduce sleep inertia.

28 Aug 2020

5 things to know about convalescent blood plasma

President Donald Trump told the American people this week that convalescent plasma is a potential new treatment for COVID-19.

27 Aug 2020

Gout drug may improve heart function in individuals with congenital heart disease

A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.

27 Aug 2020

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.

26 Aug 2020

Consuming personal fecal microbiome when dieting may limit weight regain, study shows

People who consume frozen microbiome capsules derived from their own feces when dieting may limit their weight regain, according to a new study published in Gastroenterology, conducted by a team of researchers led by researchers at Ben-Gurion University of the Negev.

26 Aug 2020

LA hospital seeks vaccine trial participants among its own high-risk patients

The patients at Dr. Eric Daar's hospital are at high risk for serious illness from COVID-19, and he's determined to make sure they're part of the effort to fight the disease.

26 Aug 2020

Vitamin D supplements do not prevent severe asthma attacks in children

Contrary to earlier results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

25 Aug 2020

Placebo News and Research

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

NAMS publishes the 2020 Genitourinary Syndrome Of Menopause Position Statement

Dr. Fauci says COVID vaccine trials could end early if results are overwhelming

BCG vaccine offers protection for elderly people against respiratory infections

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

New dietary intervention improves pain and other symptoms in veterans with Gulf War Illness

SGLT2 inhibitors can slow CKD progression

Gout medication reduces major cardiovascular events in heart patients

Antihypertensive drugs are not linked to cancer, shows study

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes

A coffee and quick catnap can improve alertness during nightshift

5 things to know about convalescent blood plasma

Gout drug may improve heart function in individuals with congenital heart disease

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Consuming personal fecal microbiome when dieting may limit weight regain, study shows

LA hospital seeks vaccine trial participants among its own high-risk patients

Vitamin D supplements do not prevent severe asthma attacks in children

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News